Health / Medical Topics

    Progenipoietin

    A recombinant, chimeric, dual-receptor agonist fusion protein with immunohematopoietic activity. Progenipoietin (ProGP) consists of portions of the ligands for granulocyte colony-stimulating factor (G-CSF) and human fetal liver tyrosine kinase-3 (FLT3); variants progenipoietin-1, 2 and 3 differ in the orientation of the two receptor agonists. ProGP binds simultaneously to G-CSF and FLT3 receptors with receptor affinities approximately two- to three-fold higher than the respective native ligands. When administered in vivo, this agent may augment the number of circulating granulocytes and dendritic cells (DCs). ProGP may promote the proliferation of and prevent apoptosis in several human hematopoietic cell lineages, exhibiting the additive activities of a combination of C-GSF and FLT3. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    An analysis (often in graphical form) representing the extent to which something exhibits various characteristics.
    Any individual test given to a laboratory as part of a proficiency test.
    A program for the determination of laboratory performance where individual labs perform the same test on the same or similar items or…
    A courtesy title for a teacher of the highest academic rank in a college or university.
    Health care professional business directed towards treatment and care of patients.
    A formal group of people that exists to further a particular profession.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact